Robert Hill
Vorstandsvorsitzender bei TAE Life Sciences LLC
Aktive Positionen von Robert Hill
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
TAE Life Sciences LLC
TAE Life Sciences LLC Pharmaceuticals: MajorHealth Technology TAE Life Sciences LLC is a privately-held biotechnology company that is developing a new biologically-targeted radiation therapy based on boron neutron capture therapy (BNCT). The company is based in Foothill Ranch, CA. The company is committed to developing next-generation targeted boron drugs and a low-energy accelerator-based neutron source that can treat patients with the most aggressive and recurrent cancers. TAE Life Sciences' Alphabeam™ neutron system and targeted boron drugs are currently in development and have not been approved for sale. Robert W. Hill has been the CEO of the company since 2019. | Vorstandsvorsitzender | 25.07.2023 | - |
Geschäftsführer | 07.01.2019 | - |
Karriereverlauf von Robert Hill
Ehemalige bekannte Positionen von Robert Hill
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ACCURAY INCORPORATED | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2007 | 01.11.2017 |
Corporate Officer/Principal | 01.11.2017 | 01.11.2018 | |
North American Scientific, Inc.
North American Scientific, Inc. Electronic Equipment/InstrumentsElectronic Technology North American Scientific, Inc. manufactures and markets medical devices for the radiation oncology community. It offers intensity modulated and image guided radiation therapy products and services, as well as brachytherapy seeds used in the treatment of prostate cancer. The company also offers iodine-based and palladium-based implantable brachytherapy seeds for the treatment of prostate cancer. It provides a line of brachytherapy seeds for use in the treatment of ocular melanoma and other solid tumor applications. The company manufactures other radio isotopic products used in various medical, environmental, research and industrial applications. North American Scientific was incorporated in 1990 and is headquartered in Chatsworth, CA. | Corporate Officer/Principal | - | - |
Ausbildung von Robert Hill
Carnegie Mellon University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Operativ
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 2 |
Electronic Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ACCURAY INCORPORATED | Health Technology |
Private Unternehmen | 2 |
---|---|
North American Scientific, Inc.
North American Scientific, Inc. Electronic Equipment/InstrumentsElectronic Technology North American Scientific, Inc. manufactures and markets medical devices for the radiation oncology community. It offers intensity modulated and image guided radiation therapy products and services, as well as brachytherapy seeds used in the treatment of prostate cancer. The company also offers iodine-based and palladium-based implantable brachytherapy seeds for the treatment of prostate cancer. It provides a line of brachytherapy seeds for use in the treatment of ocular melanoma and other solid tumor applications. The company manufactures other radio isotopic products used in various medical, environmental, research and industrial applications. North American Scientific was incorporated in 1990 and is headquartered in Chatsworth, CA. | Electronic Technology |
TAE Life Sciences LLC
TAE Life Sciences LLC Pharmaceuticals: MajorHealth Technology TAE Life Sciences LLC is a privately-held biotechnology company that is developing a new biologically-targeted radiation therapy based on boron neutron capture therapy (BNCT). The company is based in Foothill Ranch, CA. The company is committed to developing next-generation targeted boron drugs and a low-energy accelerator-based neutron source that can treat patients with the most aggressive and recurrent cancers. TAE Life Sciences' Alphabeam™ neutron system and targeted boron drugs are currently in development and have not been approved for sale. Robert W. Hill has been the CEO of the company since 2019. | Health Technology |
- Börse
- Insiders
- Robert Hill
- Erfahrung